Episurf Medical announces outcome of preferential rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE UNITED KINGDOM, JAPAN, NEW ZEALAND, SINGAPORE, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFULThrough the rights issue, Episurf Medical AB (publ) (”Episurf Medical” or the ”Company”) will receive proceeds amounting to approximately SEK 51m before deduction of costs related to the rights issue. 13,884,906 shares, corresponding to approximately 40.7 per cent of the rights issue, were